Eldelumab (Synonyms: BMS-936557; MDX-1100) |
| Catalog No.GC66332 |
Eldelumab (BMS-936557) est un anticorps monoclonal humanisé anti-CXCL10 (IP-10) (type IgG1). Eldelumab se lie sélectivement À CXCL10 et bloque le flux de calcium et la migration cellulaire induits par CXCL10. Eldelumab peut être utilisé dans des études sur les maladies auto-immunes et auto-inflammatoires telles que la polyarthrite rhumatoÏde, la colite ulcéreuse et la maladie de Crohn.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 946414-98-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Eldelumab (BMS-936557) is a humanised anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease[1][2].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *